Abstract: Scleritine is used as a protective agent for cells against toxic agents, in particular chemical or physical agents. One or more embodiments relate to a dermatological and/or cosmetic composition, which protects the skin against toxic agents, characterized in that it comprises Scleritine in at least one excipient or vehicle adapted to a topical application. One or more embodiments concerns the pharmaceutical or cosmetic industry and more specifically the formulation of pharmaceutical or cosmetic compositions intended to protect cells against toxic agents.

Abstract: The present invention relates to a water-in-oil surfactant consisting of a mixture of compounds of formula (I): wherein the compound of formula (I) has an average degree of polymerisation n of between 4 and 6, R1, R2 and R3 being, independently of one another, a hydrogen atom or a group R4 derived from at least one carboxylic acid, the carboxylic acid being 12-hydroxystearic acid or a mixture of 12-hydroxystearic acid and ricinoleic acid. The present invention also relates to a surfactant composition and to a cosmetic composition comprising this surfactant.

Abstract: The present invention belongs to the area of cosmetics, especially to a delivery system for actives to the skin, such as face masks and facial masks. Particularly, the present invention refers to a delivery system consisting of a basic body comprises nonwoven fibrous materials and an active-substance preparation which is an o/w emulsion or w/o emulsion, and a wetting liquid that comprises one or more actives to activate the delivery system.

Abstract: The present invention relates to novel 1-hexyl-1H-pyrazole-4,5-diamine derivative compounds of formula (I), to a composition for oxidation dyeing of the keratin fibres containing same, to a process for preparing the compounds of formula (I), to reaction intermediates, to an oxidation dyeing process using the composition, to the use of the compounds of formula (I) for oxidation dyeing of keratin fibres, and also to a kit; and to the 1-hexyl-4,5-diaminopyrazole derivative compounds of formula (I) below: and also the addition salts thereof with organic or mineral acids, the tautomers thereof, and the solvates thereof such as hydrates, in which ALK is as defined in the description.

Abstract: A hair cosmetic containing (A) a specified quaternary ammonium salt, (B) a dimethylpolysiloxane having a weight average molecular weight of 300 or more and 3,000 or less, and water, the hair cosmetic being used by applying on the hair and then rinsing away, wherein the content of the component (B) is 0.5 mass % or more and 60 mass % or less, and a receding contact angle (?R) of water droplet as measured by the expansion-contraction method with respect to the surface of a polyethylene plate which is applied with the hair cosmetic and then subjected to water washing is 82° or more and 110° or less. A treatment method of hair including (I) applying the hair cosmetic on the hair and spreading it over the entire hair, and (II) rinsing away the hair cosmetic with water from the entire hair.

Abstract: The present invention relates to a composition for keratin fibers comprising: (a) at least one non-neutralized anionic surfactant; (b) at least one non-ionic surfactant; (c) at least one fatty alcohol; and (d) at least one alkaline agent, wherein the composition does not comprise more than 2% by weight of a phosphoric surfactant. The present invention can provide the composition for keratin fibers which can suppress its ammonium odor and have improved stability.

Abstract: The present disclosure relates to mucoadhesive preparation comprising chitosan, and methods thereof. Further, the present disclosure relates to applications of the mucoadhesive preparation.

Abstract: This disclosure relates to microcapsule particles for targeted delivery of drugs. In certain embodiments, the particles comprise polyelectrolyte polymers, e.g., layers of anionic polymers and cationic polymers. In certain embodiments, the particles have a fibrinogen coating. In certain embodiments, the particles contain a polysaccharide core and/or a polysaccharide coating encapsulating drugs, proteins, clotting agents, coagulation factors, or anticoagulants. In certain embodiments, this disclosure contemplates methods of using particles disclosed herein to prevent or reduce onset of or duration of bleeding. In certain embodiments, this disclosure contemplates methods of using particles disclosed herein to prevent or reduce onset of blood clotting.

Abstract: An object of the present invention is to provide a cosmetic composition for use in sunscreen that exhibits a sufficient effect with a reduced content of a UV protection agent, and to provide a cosmetic composition for use in sunscreen that has excellent texture, usability, and antioxidant action, while having a UV protection effect. In order to achieve this object, an emulsified cosmetic composition for use in sunscreen comprising (A) trans-resveratrol polysaccharide and (B) a UV protection agent is provided.

Abstract: One aspect of the present invention is directed to a composition. The composition includes a dispersion inducer comprising: H3C—(CH2)n—CHmCHmR, where is a single or double carbon-carbon bond, m is 1 or 2, n is 2 to 15, and R is a carboxylic acid, a salt, an ester, or an amide, where the ester or amide is an isostere or biostere of the carboxylic acid. The composition additionally contains an additive component selected from one or more of the group consisting of biocides, surfactants, antibiotics, antiseptics, detergents, chelating agents, virulence factor inhibitors, gels, polymers, pastes, edible products, and chewable products. The composition is formulated so that when it is contacted with a biofilm produced by a microorganism, where the biofilm comprises a matrix and microorganism on a surface, the dispersion inducer selectively acts on the microorganism and has a suitable biological response without a required direct effect on the matrix to disperse the biofilm.

Abstract: Provided are carotenoid-containing particles having, for preventing exudation of carotenoid at the time of tableting and during storage, a structure in which a carotenoid is dispersed in an agar gel containing a cyclodextrin and/or a plant protein.

Abstract: The invention relates to methods for preparing dispersible curcuminoid compositions.

Abstract: Methods of treating a wound of a subject using a composition which includes graphene oxide (GO) and hyaluronic acid (HA) that are covalently linked, XAV939, and water. The composition can also include a surfactant, such as PEG. The composition can be topically administered to a subject to treat a wound of the subject.

Abstract: A method of protecting the internal protein of hair from damage, comprising the step of applying, to the hair, a hair treatment composition comprising a lactone, a disaccharide, an inorganic salt and an organic acid or salt thereof, having a pH in the range of from 3 to 6.5, prior to the application of a damage insult to the hair, and a use of such a hair treatment composition, in the treatment of hair, to protect hair from damage.

Abstract: Disclosed are topical composition for delivery of an active agent to keratinous tissue, comprising a low molecular weight chitosan that is covalently modified chitosan with octane sulfonic acid which are attached to the chitosan via sulfonamide linkages (OsC), an effective amount of an active agent, and a carrier, and wherein the chitosan has a molecular weight of about 50 kD to about 150 kD. Also disclosed are methods of making the compositions and methods of using the compositions that entail topical application.

Abstract: The present invention relates to a cosmetic and/or dermatological composition comprising, in a physiologically acceptable medium: a) at least some hydrophobic aerogel particles, b) at least some silicone elastomer particles, c) at least one particle that absorbs sebum. The invention also relates to a process for making the skin matt and/or for reducing its shine.

Abstract: The present invention relates to the use, in a cosmetic, dermatological or pharmaceutical composition, of at least one compound of formula (I): in which: R2 represents a hydrogen atom or a methyl or ethyl radical; R3 represents a linear C1-C12 alkyl radical, optionally substituted with a hydroxyl group; or a linear C2-C12 alkenyl radical, optionally substituted with a hydroxyl group; as a preserving agent. The invention also relates to certain novel compounds and to the cosmetic, dermatological or pharmaceutical compositions comprising them.

Abstract: A composition for treating a wound includes graphene oxide (GO) and hyaluronic acid (HA) that are covalently linked, XAV939, and water. The composition can also include a surfactant, such as PEG. The composition can be topically administered to a subject to treat a wound of the subject. Methods of treating a wound using the composition are also provided.

Abstract: The present invention relates to a cosmetic composition comprising, at least: (i) at least one composite pigment comprising at least one small particle with a mean particle size of more than 100 nm and less than 1 ?m, preferably less than 600 nm, and more preferably less than 400 nm, wherein the surface of the small particle is at least in part covered with at least one coating layer comprising at least one inorganic or organic particulate solid UV filter; (ii) at least one organopolysiloxane elastomer; and (iii) at least one oil absorbing agent with oil absorption capability of 1 ml/1 g or more in an amount of more than 1% by weight relative to the total weight of composition.

Abstract: An inverse emulsion copolymer composition comprises (A) an aqueous phase comprising a cross-linked hydrophilic polyelectrolyte copolymer (A?) obtained by the free radical copolymerisation of: (i) at least one anionic ethylenically unsaturated monomer bearing a negatively charged group and one polymerisable C?C double bond, or at least one cationic ethylenically unsaturated monomer bearing a positively charged group and one polymerisable C?C double bond, and (ii) at least one non-ionic ethylenically unsaturated cross-linking monomer bearing at least two polymerisable C?C double bonds, and (iii) optionally, one or more hydrophilic non-ionic ethylenically unsaturated monomers bearing one polymerisable C?C double bond, (B) an oil phase comprising a carrier oil (C), (D) (i) at least one water-in-oil emulsifying surfactant, and (D) (ii) at least one oil-in-water emulsifying surfactant; characterised in that the carrier oil component (C) of the oil phase comprises from 75% to 100%, by weight of the said carrier oil